ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

LFCR Lifecore Biomedical Inc

6.32
-0.03 (-0.47%)
Última actualización: 10:47:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Lifecore Biomedical Inc LFCR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.03 -0.47% 6.32 10:47:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.43 6.27 6.51 6.35
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/4/202415:30GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
01/4/202407:00GLOBELifecore Biomedical Provides Business Update Outlining..
26/3/202415:30GLOBELifecore Biomedical Announces Pending Change of Auditor and..
20/3/202406:30GLOBELifecore Biomedical Concludes Strategic Evaluation Process,..
20/3/202406:00GLOBELifecore Biomedical Completes Restatements and Files Form..
29/2/202415:25EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202415:12EDGAR2Form 8-K - Current report
16/2/202415:05GLOBELifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice..
14/2/202414:39EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
02/2/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202413:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202415:51EDGAR2Form 8-K - Current report
12/1/202415:43GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
10/1/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202416:22EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
05/1/202415:09EDGAR2Form 8-K - Current report
05/1/202407:00GLOBELifecore Biomedical Expands Relationship with Existing..
04/1/202415:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13/12/202306:30GLOBELifecore Biomedical Provides Business Update
20/11/202315:09EDGAR2Form 8-K - Current report
20/11/202315:05GLOBECompany Reaches Favorable Resolution Regarding..
31/10/202305:17EDGAR2Form 8-K - Current report
18/10/202315:07EDGAR2Form 8-K - Current report
18/10/202315:05GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
17/10/202304:00PRNUSSHL Medical and Lifecore Biomedical enter co-marketing..
10/10/202315:07EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/10/202315:05GLOBELifecore Biomedical Provides Update for Development..
31/8/202306:39EDGAR2Form 8-K - Current report
31/8/202306:30GLOBELifecore Biomedical Reports Fourth Quarter and Full Fiscal..
22/8/202315:11EDGAR2Form 8-K - Current report
22/8/202315:06GLOBELifecore Biomedical Sets Fourth Quarter 2023 Earnings..
22/8/202315:05GLOBELifecore Biomedical, Inc. Receives Notice from Nasdaq..
15/8/202316:07EDGAR2Form SC 13D/A - General statement of acquisition of..
14/8/202315:11EDGAR2Form NT 10-K - Notification of inability to timely file Form..
07/7/202315:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/6/202313:46EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/6/202315:32EDGAR2Form SC 13D/A - General statement of acquisition of..
01/6/202306:15GLOBELifecore Biomedical Reports Third Quarter Fiscal Year 2023..
22/5/202315:51GLOBELifecore Biomedical Enters into $150.0 Million in New..
22/5/202315:49GLOBELifecore Biomedical Sets Third Quarter 2023 Earnings..

Su Consulta Reciente

Delayed Upgrade Clock